Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

August 07, 2023 13:46 (London Time)

Pacira Biosciences

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: PCRX
Sentiment: 0.5848
MarketCap: 1,655,604,396.0
High: 39.6 Low: 38.91

Open: 39.01 Close: 39.01 Change: 0.01

What an AI can tell you about Pacira Biosciences before investing.

Are looking for the most relevant information about Pacira Biosciences? Investor spend a lot of time searching for information to make investment decisions in Pacira Biosciences. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pacira Biosciences are: Pacira, BioSciences, price, report, Q2, earnings, Biosciences, and the most common words in the summary are: pacira, bioscience, inc, share, price, news, market, . One of the sentences in the summary was: Pacira Biosciences Inc reported earnings per share of $0.96 for the …

Concept Map

...

Semantic Network

...

Stock Summary

Pacira BioSciences reports mixed Q2 earnings; updates FY23 outlook. Q2 Non-GAAP EPS of $0.78 beats by $0.02. Pacira Biosciences has an average price target.

Today's Summary

Pacira BioSciences reports mixed Q2 earnings; updates FY23 outlook. Q2 Non-GAAP EPS of $0.78 beats by $0.02. Seeking Alpha Join the Summer Sale! Home Analysis News Market Data Investing Groups. Pacira Biosciences Inc reported earnings per share of $0.96 for the current quarter and recorded sales of $182.3 million. Pacira BioSciences has an average price target of $58.25 with a high of $68.00 and a low of $50.00. Analysts expect Pacira Biosciences Inc. share price to average $61.78 over the next year. TD Cowen raised Pacira BioSciences from a “market perform” rating to an “outperform’s’ price target on Thursday.

Today's News

Pacira BioSciences reports mixed Q2 earnings; updates FY23 outlook. Q2 Non-GAAP EPS of $0.78 beats by $0.02. Seeking Alpha Join the Summer Sale! Home Analysis News Market Data Investing Groups. Pacira Biosciences Inc reported earnings per share of $0.96 for the current quarter and recorded sales of $182.3 million. Pacira BioSciences has an average price target of $58.25 with a high of $68.00 and a low of $50.00. Analysts expect Pacira Biosciences Inc. share price to average $61.78 over the next year. TD Cowen raised Pacira BioSciences from a “market perform” rating to an “outperform’s’ price target on Thursday.

Stock Profile

" Pacira BioSciences reports mixed Q2 earnings; updates FY23 outlook. Q2 Non-GAAP EPS of $0.78 beats by $0.02. Seeking Alpha Join the Summer Sale! Home Analysis News Market Data Investing Groups. Pacira Biosciences Inc reported earnings per share of $0.96 for the current quarter and recorded sales of $182.3 million. Pacira BioSciences has an average price target of $58.25 with a high of $68.00 and a low of $50.00. Analysts expect Pacira Biosciences Inc. share price to average $61.78 over the next year. TD Cowen raised Pacira BioSciences from a “market perform” rating to an “outperform’s’ price target on Thursday."

Keywords

How much time have you spent trying to decide whether investing in Pacira Biosciences? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pacira Biosciences are: Pacira, BioSciences, price, report, Q2, earnings, Biosciences, and the most common words in the summary are: pacira, bioscience, inc, share, price, news, market, . One of the sentences in the summary was: Pacira Biosciences Inc reported earnings per share of $0.96 for the current quarter and recorded sales of $182.3 million. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pacira #bioscience #inc #share #price #news #market.

Read more →

Related Results

...
February 06, 2024 3:39 (London Time)

Pacira Biosciences

Pacira BioSciences ( NASDAQ:PCRX – Get Free Report ) last released its quarterly earnings data on Thursday, November 2nd. Research analysts forecast…
Sector: Pharmaceuticals
Ticker: PCRX
Sentiment: 0.5106
MarketCap: 1,408,919,939.0
High: 31.48 Low: 29.98

Open: 30.08 Close: 31.14 Change: 1.06

Read more →
...
August 13, 2023 11:47 (London Time)

Pacira Biosciences

Pacira BioSciences Inc. is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes …
Sector: Pharmaceuticals
Ticker: PCRX
Sentiment: 0.4939
MarketCap: 1,743,887,629.0
High: 38.27 Low: 37.01

Open: 37.84 Close: 37.57 Change: -0.27

Read more →
...
October 17, 2023 8:24 (London Time)

Pacira Biosciences

Pacira BioSciences Inc. stock price & news - wsj. PCRX (U.S.: Nasdaq) Overview Profile Financials Income Statement Balance Sheet Cash Flow Research …
Sector: Pharmaceuticals
Ticker: PCRX
Sentiment: 0.8176
MarketCap: 1,375,800,621.0
High: 30.39 Low: 29.02

Open: 29.3 Close: 29.64 Change: 0.34

Read more →
...
August 07, 2023 13:46 (London Time)

Pacira Biosciences

Pacira BioSciences reports mixed Q2 earnings; updates FY23 outlook. Q2 Non-GAAP EPS of $0.78 beats by $0.02. Seeking Alpha Join the Summer Sale! Hom…
Sector: Pharmaceuticals
Ticker: PCRX
Sentiment: 0.5848
MarketCap: 1,655,604,396.0
High: 39.6 Low: 38.91

Open: 39.01 Close: 39.01 Change: 0.01

Read more →